vs
Fortrea Holdings Inc.（FTRE）与RadNet, Inc.（RDNT）财务数据对比。点击上方公司名可切换其他公司
Fortrea Holdings Inc.的季度营收约是RadNet, Inc.的1.2倍（$660.5M vs $547.7M）。RadNet, Inc.净利率更高（-0.1% vs -4.9%，领先4.8%）。RadNet, Inc.同比增速更快（14.8% vs -5.2%）。过去两年RadNet, Inc.的营收复合增速更高（12.6% vs -0.1%）
Fortrea Holdings Inc.是一家总部位于美国北卡罗来纳州达勒姆、注册地为特拉华州的合同研究组织，业务覆盖90个国家，主要服务制药、生物技术和医疗器械行业客户，为相关领域的研发提供专业支持。
RadNet是美国领先的放射医疗服务企业，总部位于加利福尼亚州洛杉矶，是美国规模最大的独立固定地址诊断影像中心运营商，按网点数量及年度影像业务收入计均居行业首位。截至2025年，该公司在全美8个州持有或运营超400家影像中心，提供门诊诊断影像服务。
FTRE vs RDNT — 直观对比
营收规模更大
FTRE
是对方的1.2倍
$547.7M
营收增速更快
RDNT
高出20.0%
-5.2%
净利率更高
RDNT
高出4.8%
-4.9%
两年增速更快
RDNT
近两年复合增速
-0.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $660.5M | $547.7M |
| 净利润 | $-32.5M | $-597.0K |
| 毛利率 | — | — |
| 营业利润率 | -2.1% | 5.1% |
| 净利率 | -4.9% | -0.1% |
| 营收同比 | -5.2% | 14.8% |
| 净利润同比 | 46.9% | -111.2% |
| 每股收益（稀释后） | $-0.25 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTRERDNT
| Q4 25 | $660.5M | $547.7M | ||
| Q3 25 | $701.3M | $522.9M | ||
| Q2 25 | $710.3M | $498.2M | ||
| Q1 25 | $651.3M | $471.4M | ||
| Q4 24 | $697.0M | $477.1M | ||
| Q3 24 | $674.9M | $461.1M | ||
| Q2 24 | $662.4M | $459.7M | ||
| Q1 24 | $662.1M | $431.7M |
净利润FTRERDNT
| Q4 25 | $-32.5M | $-597.0K | ||
| Q3 25 | $-15.9M | $5.4M | ||
| Q2 25 | $-374.9M | $14.5M | ||
| Q1 25 | $-562.9M | $-37.9M | ||
| Q4 24 | $-61.2M | $5.3M | ||
| Q3 24 | $-27.9M | $3.2M | ||
| Q2 24 | $-138.4M | $-3.0M | ||
| Q1 24 | $-101.0M | $-2.8M |
营业利润率FTRERDNT
| Q4 25 | -2.1% | 5.1% | ||
| Q3 25 | -1.2% | 5.2% | ||
| Q2 25 | -46.5% | 6.2% | ||
| Q1 25 | -79.9% | -5.1% | ||
| Q4 24 | -8.0% | 5.1% | ||
| Q3 24 | -2.7% | 7.4% | ||
| Q2 24 | -7.7% | 7.6% | ||
| Q1 24 | -5.6% | 2.6% |
净利率FTRERDNT
| Q4 25 | -4.9% | -0.1% | ||
| Q3 25 | -2.3% | 1.0% | ||
| Q2 25 | -52.8% | 2.9% | ||
| Q1 25 | -86.4% | -8.0% | ||
| Q4 24 | -8.8% | 1.1% | ||
| Q3 24 | -4.1% | 0.7% | ||
| Q2 24 | -20.9% | -0.6% | ||
| Q1 24 | -15.3% | -0.6% |
每股收益（稀释后）FTRERDNT
| Q4 25 | $-0.25 | $0.00 | ||
| Q3 25 | $-0.17 | $0.07 | ||
| Q2 25 | $-4.14 | $0.19 | ||
| Q1 25 | $-6.25 | $-0.51 | ||
| Q4 24 | $-0.68 | $0.08 | ||
| Q3 24 | $-0.31 | $0.04 | ||
| Q2 24 | $-1.55 | $-0.04 | ||
| Q1 24 | $-1.13 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.6M | $767.2M |
| 总债务越低越好 | — | $1.1B |
| 股东权益账面价值 | $563.5M | $1.1B |
| 总资产 | $2.7B | $3.8B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资FTRERDNT
| Q4 25 | $174.6M | $767.2M | ||
| Q3 25 | $131.3M | $804.7M | ||
| Q2 25 | $81.2M | $833.2M | ||
| Q1 25 | $101.6M | $717.3M | ||
| Q4 24 | $118.5M | $740.0M | ||
| Q3 24 | $105.3M | $748.9M | ||
| Q2 24 | $126.2M | $741.7M | ||
| Q1 24 | $92.8M | $527.0M |
总债务FTRERDNT
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $834.6M |
股东权益FTRERDNT
| Q4 25 | $563.5M | $1.1B | ||
| Q3 25 | $580.8M | $1.1B | ||
| Q2 25 | $589.2M | $932.3M | ||
| Q1 25 | $858.8M | $898.1M | ||
| Q4 24 | $1.4B | $902.3M | ||
| Q3 24 | $1.5B | $895.3M | ||
| Q2 24 | $1.5B | $881.0M | ||
| Q1 24 | $1.6B | $873.0M |
总资产FTRERDNT
| Q4 25 | $2.7B | $3.8B | ||
| Q3 25 | $2.7B | $3.7B | ||
| Q2 25 | $2.8B | $3.5B | ||
| Q1 25 | $3.1B | $3.3B | ||
| Q4 24 | $3.6B | $3.3B | ||
| Q3 24 | $3.7B | $3.3B | ||
| Q2 24 | $3.6B | $3.2B | ||
| Q1 24 | $4.2B | $3.0B |
负债/权益比FTRERDNT
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 1.18× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.13× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | — | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $129.1M | $84.2M |
| 自由现金流经营现金流 - 资本支出 | $121.6M | — |
| 自由现金流率自由现金流/营收 | 18.4% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $88.3M | — |
8季度趋势，按日历期对齐
经营现金流FTRERDNT
| Q4 25 | $129.1M | $84.2M | ||
| Q3 25 | $86.8M | $52.8M | ||
| Q2 25 | $21.8M | $120.3M | ||
| Q1 25 | $-124.2M | $41.5M | ||
| Q4 24 | $17.1M | $42.5M | ||
| Q3 24 | $-2.4M | $57.4M | ||
| Q2 24 | $273.7M | $116.0M | ||
| Q1 24 | $-25.6M | $17.1M |
自由现金流FTRERDNT
| Q4 25 | $121.6M | — | ||
| Q3 25 | $79.5M | — | ||
| Q2 25 | $14.3M | — | ||
| Q1 25 | $-127.1M | — | ||
| Q4 24 | $13.9M | — | ||
| Q3 24 | $-10.6M | — | ||
| Q2 24 | $262.5M | — | ||
| Q1 24 | $-34.9M | — |
自由现金流率FTRERDNT
| Q4 25 | 18.4% | — | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | -19.5% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | -5.3% | — |
资本支出强度FTRERDNT
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.4% | — |
现金转化率FTRERDNT
| Q4 25 | — | — | ||
| Q3 25 | — | 9.75× | ||
| Q2 25 | — | 8.33× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.96× | ||
| Q3 24 | — | 17.89× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTRE
暂无分部数据
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
